Senior insider sale
Chief Development Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$810.7K
20K shares
What this filing means
PIZZUTI DANA plans to sell 20K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $810.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/1/2025ACC: 0001950047-25-009572
Officer· Chief Development Officer
Since Sep 2022
20K
Shares to sell
$810.7K
Approx. market value
5K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/1/2025
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/1/2025 | Exercise of Stock Options Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5K
Market value
$213.3K
11/3/2025
—Completed
Units to sell
5K
Market value
$209.1K
10/1/2025
—Completed
Units to sell
5K
Market value
$160.5K
9/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5K
Market value
$227.8K
12/1/2025
Total
Units
20K
Value
$810.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/3/2025 | 5K | $213.3K | — | Completed |
10/1/2025 | 5K | $209.1K | — | Completed |
9/2/2025 | 5K | $160.5K | — | Completed |
| Planned — Approximate Date | ||||
12/1/2025 | 5K | $227.8K | NASDAQ | Planned |
| Total | 20K | $810.7K | ||